Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced Upper Tract Urothelial Carcinoma: a Prospective Observational Cohort Study

NCT06598761 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06598761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06598761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced Upper Tract Urothelial Carcinoma: a Prospective Observational Cohort Study
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2022
Completion date
August 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma, renal pelvic carcinoma, ureter cancer